Regulated Electric
Compare Stocks
2 / 10Stock Comparison
SREA vs EXC
Revenue, margins, valuation, and 5-year total return — side by side.
Regulated Electric
SREA vs EXC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Regulated Electric | Regulated Electric |
| Market Cap | $14.05B | $46.64B |
| Revenue (TTM) | $13.70B | $24.32B |
| Net Income (TTM) | $1.83B | $2.82B |
| Gross Margin | 52.1% | 42.5% |
| Operating Margin | 23.7% | 20.8% |
| Forward P/E | 4.2x | 16.2x |
| Total Debt | $37.46B | $49.69B |
| Cash & Equiv. | $2M | — |
SREA vs EXC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sempra (SREA) | 100 | 84.3 | -15.7% |
| Exelon Corporation (EXC) | 100 | 169.0 | +69.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SREA vs EXC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SREA carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 0.83, yield 11.4%
- Lower volatility, beta 0.83, Low D/E 89.2%, current ratio 0.01x
- Beta 0.83, yield 11.4%, current ratio 0.01x
EXC is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 5.3%, EPS growth 11.4%, 3Y rev CAGR 8.3%
- 131.2% 10Y total return vs SREA's 24.3%
- 5.3% revenue growth vs SREA's 3.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.3% revenue growth vs SREA's 3.9% | |
| Value | Lower P/E (4.2x vs 16.2x) | |
| Quality / Margins | 13.4% margin vs EXC's 11.6% | |
| Stability / Safety | Lower D/E ratio (89.2% vs 172.5%) | |
| Dividends | 11.4% yield, 3-year raise streak, vs EXC's 3.5% | |
| Momentum (1Y) | +11.8% vs EXC's +3.9% | |
| Efficiency (ROA) | 2.5% ROA vs SREA's 1.8%, ROIC 5.1% vs 3.2% |
SREA vs EXC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SREA vs EXC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — SREA and EXC each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EXC is the larger business by revenue, generating $24.3B annually — 1.8x SREA's $13.7B. Profitability is closely matched — net margins range from 13.4% (SREA) to 11.6% (EXC). On growth, EXC holds the edge at +9.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $13.7B | $24.3B |
| EBITDAEarnings before interest/tax | $5.8B | $8.7B |
| Net IncomeAfter-tax profit | $1.8B | $2.8B |
| Free Cash FlowCash after capex | -$10.2B | -$1.6B |
| Gross MarginGross profit ÷ Revenue | +52.1% | +42.5% |
| Operating MarginEBIT ÷ Revenue | +23.7% | +20.8% |
| Net MarginNet income ÷ Revenue | +13.4% | +11.6% |
| FCF MarginFCF ÷ Revenue | -74.4% | -6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.1% | +9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -48.1% | +22.9% |
Valuation Metrics
SREA leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 7.8x trailing earnings, SREA trades at a 54% valuation discount to EXC's 16.9x P/E. On an enterprise value basis, EXC's 11.0x EV/EBITDA is more attractive than SREA's 74.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $14.0B | $46.6B |
| Enterprise ValueMkt cap + debt − cash | $51.5B | $96.3B |
| Trailing P/EPrice ÷ TTM EPS | 7.82x | 16.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.22x | 16.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.68x |
| EV / EBITDAEnterprise value multiple | 74.65x | 10.96x |
| Price / SalesMarket cap ÷ Revenue | 1.03x | 1.92x |
| Price / BookPrice ÷ Book value/share | 0.33x | 1.62x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
SREA leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
EXC delivers a 10.0% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $5 for SREA. SREA carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to EXC's 1.73x. On the Piotroski fundamental quality scale (0–9), SREA scores 4/9 vs EXC's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +10.0% |
| ROA (TTM)Return on assets | +1.8% | +2.5% |
| ROICReturn on invested capital | +3.2% | +5.1% |
| ROCEReturn on capital employed | +5.7% | — |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.89x | 1.73x |
| Net DebtTotal debt minus cash | $37.5B | $49.7B |
| Cash & Equiv.Liquid assets | $2M | — |
| Total DebtShort + long-term debt | $37.5B | $49.7B |
| Interest CoverageEBIT ÷ Interest expense | 2.81x | — |
Total Returns (Dividends Reinvested)
EXC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EXC five years ago would be worth $17,181 today (with dividends reinvested), compared to $10,461 for SREA. Over the past 12 months, SREA leads with a +11.8% total return vs EXC's +3.9%. The 3-year compound annual growth rate (CAGR) favors EXC at 5.8% vs SREA's 1.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.2% | +6.1% |
| 1-Year ReturnPast 12 months | +11.8% | +3.9% |
| 3-Year ReturnCumulative with dividends | +5.5% | +18.6% |
| 5-Year ReturnCumulative with dividends | +4.6% | +71.8% |
| 10-Year ReturnCumulative with dividends | +24.3% | +131.2% |
| CAGR (3Y)Annualised 3-year return | +1.8% | +5.8% |
Risk & Volatility
EXC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EXC is the less volatile stock with a -0.14 beta — it tends to amplify market swings less than SREA's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.83x | -0.14x |
| 52-Week HighHighest price in past year | $23.84 | $50.65 |
| 52-Week LowLowest price in past year | $6.33 | $41.71 |
| % of 52W HighCurrent price vs 52-week peak | +90.2% | +91.2% |
| RSI (14)Momentum oscillator 0–100 | 59.9 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 47K | 8.1M |
Analyst Outlook
SREA leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, SREA offers the higher dividend yield at 11.42% vs EXC's 3.46%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $49.18 |
| # AnalystsCovering analysts | — | 35 |
| Dividend YieldAnnual dividend ÷ price | +11.4% | +3.5% |
| Dividend StreakConsecutive years of raises | 3 | 1 |
| Dividend / ShareAnnual DPS | $2.46 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.8% | 0.0% |
SREA leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). EXC leads in 2 (Total Returns, Risk & Volatility). 1 tied.
SREA vs EXC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SREA or EXC a better buy right now?
For growth investors, Exelon Corporation (EXC) is the stronger pick with 5.
3% revenue growth year-over-year, versus 3. 9% for Sempra (SREA). Sempra (SREA) offers the better valuation at 7. 8x trailing P/E (4. 2x forward), making it the more compelling value choice. Analysts rate Exelon Corporation (EXC) a "Hold" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SREA or EXC?
On trailing P/E, Sempra (SREA) is the cheapest at 7.
8x versus Exelon Corporation at 16. 9x. On forward P/E, Sempra is actually cheaper at 4. 2x.
03Which is the better long-term investment — SREA or EXC?
Over the past 5 years, Exelon Corporation (EXC) delivered a total return of +71.
8%, compared to +4. 6% for Sempra (SREA). Over 10 years, the gap is even starker: EXC returned +131. 2% versus SREA's +24. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SREA or EXC?
By beta (market sensitivity over 5 years), Exelon Corporation (EXC) is the lower-risk stock at -0.
14β versus Sempra's 0. 83β — meaning SREA is approximately -689% more volatile than EXC relative to the S&P 500. On balance sheet safety, Sempra (SREA) carries a lower debt/equity ratio of 89% versus 173% for Exelon Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SREA or EXC?
By revenue growth (latest reported year), Exelon Corporation (EXC) is pulling ahead at 5.
3% versus 3. 9% for Sempra (SREA). On earnings-per-share growth, the picture is similar: Exelon Corporation grew EPS 11. 4% year-over-year, compared to -37. 8% for Sempra. Over a 3-year CAGR, EXC leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SREA or EXC?
Sempra (SREA) is the more profitable company, earning 13.
4% net margin versus 11. 4% for Exelon Corporation — meaning it keeps 13. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SREA leads at 23. 7% versus 21. 2% for EXC. At the gross margin level — before operating expenses — EXC leads at 45. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SREA or EXC more undervalued right now?
On forward earnings alone, Sempra (SREA) trades at 4.
2x forward P/E versus 16. 2x for Exelon Corporation — 12. 0x cheaper on a one-year earnings basis.
08Which pays a better dividend — SREA or EXC?
All stocks in this comparison pay dividends.
Sempra (SREA) offers the highest yield at 11. 4%, versus 3. 5% for Exelon Corporation (EXC).
09Is SREA or EXC better for a retirement portfolio?
For long-horizon retirement investors, Exelon Corporation (EXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
14), 3. 5% yield, +131. 2% 10Y return). Both have compounded well over 10 years (EXC: +131. 2%, SREA: +24. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SREA and EXC?
Both stocks operate in the Utilities sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.